Latest Posts

: http://www.veintherapynews.com/ex-employee-char…r-financial-gain/ ‎
02 Nov 2017

Boston Scientific to distribute Veniti VICI Venous Stent

Veniti Inc., a research company in the advancement of treatment for deep venous disease, has announced that Boston Scientific will distribute its VICI Venous Stent under a limited global distribution agreement. The terms of the agreement and specific regions and countries involved were not disclosed. Physicians treat the obstructive component

0
access vascular hydropicc catheter illustration
02 Nov 2017

Access Vascular HydroPICC cath raises $4M

Medical device developer Access Vascular has raised $3.7 million to support its HydroPICC catheter designed to reduce thrombotic risk. The HydroPICC is a peripherally inserted central catheter which the Bedford, Mass.-based company claims can significantly reduce the accumulation of platelets and the risk of thrombosis. Financing will support the submission of an

0
: http://www.veintherapynews.com/ex-employee-char…r-financial-gain/ ‎
02 Nov 2017

Thrombectomy device market to reach $1.45B value by 2022

The global thrombectomy devices market is expected to reach a value of $1.45 billion by 2022, growing at a CAGR of 6.7 percent during the forecast period, according to a new Research and Markets report, “Thrombectomy Devices Market – Global Forecasts to 2022.” The growing target patient population, ongoing technological

0
02 Nov 2017

Americas will benefit most with IVC filter market growth

Market research analysts at Technavio predict that the global inferior vena cava (IVC) filter market will grow steadily during the next four years and post a CAGR of more than 11 percent by 2021. This market research analysis identifies the preference for minimally invasive procedures with improved medical imaging as

0
: http://www.veintherapynews.com/ex-employee-char…r-financial-gain/ ‎
02 Nov 2017

ElastiMed raises $1M in second funding round

In its second round of funding in October, Israeli medical startup ElastiMed has raised $1 million from a strategic investor, existing investors — The Trendlines Group and Pix Vine Capital — new private investors, and the Israeli Innovation Authority. ElastiMed, which was founded in 2015, has developed a wearable medical device

0
SHARE

Home